$0.34

0.025 (6.94%)

General Information

Bionomics Limited
BNO
http://www.bionomics.com.au
Biotechnology
173
481

Current Price Data+

Current Price $0.335
Open $0.365
High $0.365
Low $0.330
Last Close $0.360
Volume 792963
Price Movement $0.03 ( 6.94% )
  • +Security prices are delayed by least 20 minutes and are indicative only.

Stock Price

Current Broker Consensus Recommendation

Buy
3 May 2016
1

Company Overview

Business Description

Bionomics Limited (BNO) is an Australian biotechnology company focused on the discovery and development of cancer, central nervous system disorders such as anxiety, depression and Alzheimer's Disease. BNO partners with pharmaceutical companies to get the drugs through the later stages of development and into the market.

Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2017 F 0.0 9.5 0.0% 3.8 0.0 0.0% 0.0%
2016 F 0.0 -4.8 0.0% 0.0 0.0 0.0% 0.0%
2015 A -17.5 -4.2 0.0% 0.0 0.0 0.0% 0.0%

Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2015 A 2016 F 2017 F 2015 A 2016 F 2017 F 2015 A 2016 F 2017 F
Bionomics (BNO) $159M 0.0000 0.0000 0.0000 0.0000 0.0000 3.4773 0.00% 0.00% 0.00%
CSL (CSL) $50,118M 0.3109 0.0440 0.2597 29.2264 27.9959 22.2247 1.48% 1.53% 2.33%
Mesoblast (MSB) $877M 0.0000 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Monash IVF Group (MVF) $437M 1.8016 0.1736 0.0347 17.9922 15.3306 14.8163 3.75% 4.57% 4.73%
Sirtex Medical (SRX) $1,720M 0.6876 0.4570 0.4487 43.0846 29.5716 20.4119 0.67% 0.99% 1.43%

Financial Summary

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 4.71 0.00
Market 1.16 15.50 1.16 0.91
Sector 0.49 15.70 3.30 0.71

Directors

Name Position Start Date
Dr Deborah Ann Rathjen Chief Executive Officer, Managing Director 21 Jun 2000
Mr Trevor Tappenden Non-Executive Director 15 Sep 2006
Dr Errol De Souza Non-Executive Director 28 Feb 2008
Dr Alan William Dunton Non-Executive Director 24 Sep 2015
Mr Graeme Kaufman Non-Executive Director, Non-Executive Chairman 18 Sep 2012

Management

Name Position
Dr Jose Iglesias Chief Medical Officer
Dr Jens Mikkelsen Chief Scientific Officer
Jack Moschakis Company Secretary,Legal Councel

Substantial Shareholders

Holding Name
40,187,873 (9.61%) Link Traders (Aust) Pty Limited
24,241,071 (5.79%) John Leaver
24,000,000 (5.74%) Ausbil Dexia Limited
21,642,425 (5.17%) Australian National University

Calendar of Events

Date Event
16 February 2017 Report (Interim)
14 October 2016 Report (Annual)
08 August 2016 Report (Prelim)
© 2011 Morningstar, Inc. All rights reserved. The data and content contained herein are not guaranteed to be accurate, complete or timely. Neither Morningstar, nor its affiliates nor their content providers will have any liability for use or distribution of any of this information. To the extent that any of the content above constitutes advice, it is general advice that has been prepared by Morningstar Australasia Pty Ltd ABN: 95 090 665 544, AFSL: 240892 (a subsidiary of Morningstar, Inc.), without reference to your objectives, financial situation or needs. Before acting on any advice, you should consider the appropriateness of the advice and we recommend you obtain financial, legal and taxation advice before making any financial investment decision. If applicable investors should obtain the relevant product disclosure statement and consider it before making any decision to invest. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). DISCLOSURE: Employees may have an interest in the securities discussed in this report. Please refer to our Financial Services Guide (FSG) for more information at www.morningstar.com.au/fsg.asp.